Evidence map›Paper›PMID 31405854›Full record

ArticleAntimicrobial agents and chemotherapy2019

Filip Zmuda, Sharon M Shepherd, Michael A J Ferguson, David W Gray, Leah S Torrie, Manu De Rycker

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Consumption of Galactose byPathogens (Basel, Switzerland) · 2022
    Article
  2. Article
  3. Article
  4. Article
  5. Challenges in Chagas Disease Drug Development.Molecules (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Filip ZmudaDrug Discovery Unit, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Sharon M ShepherdProtein Production Team, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Michael A J FergusonDrug Discovery Unit, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
David W GrayDrug Discovery Unit, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dundee, United Kingdom d.w.gray@dundee.ac.uk m.derycker@dundee.ac.uk.
Leah S TorrieDrug Discovery Unit, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Manu De RyckerDrug Discovery Unit, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dundee, United Kingdom d.w.gray@dundee.ac.uk m.derycker@dundee.ac.uk.ORCID 0000-0002-3171-3519
University of Dundee · GB

Funding

Wellcome Trust 101842/Z13/ZWellcome Trust 203134/Z/16/ZWellcome Trust 204672/Z/16/Z
6 · The paper itself

Abstract

Chagas' disease, which is caused by the

Indexed as

Antiprotozoal AgentsChagas DiseaseDrug DiscoveryMannoseMannosephosphatesNucleotidyltransferasesPhosphotransferases (Phosphomutases)Trypanosoma cruziAntiprotozoal AgentsMannosemannose 1-phosphate guanylyltransferasemannose-6-phosphateMannosephosphatesNucleotidyltransferasesphosphomannomutasePhosphotransferases (Phosphomutases)Chagas’ diseasedrug discoveryligandabilitymannosescreeningtarget based

Identifiers

PMID31405854
PMCPMC6761512
OpenAlexW2966980904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.